The Biotech Growth Trust PLC
BIOG.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | -£77,484 | £80,346 | -£37,654 | -£209,711 |
| % Growth | -196.4% | 313.4% | 82% | – |
| Cost of Goods Sold | £1,325 | £2,347 | £5,313 | £4,802 |
| Gross Profit | -£78,809 | £77,999 | -£42,967 | -£214,513 |
| % Margin | 101.7% | 97.1% | 114.1% | 102.3% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £3,621 | £3,169 | £3,520 | £3,218 |
| SG&A Expenses | £3,707 | £3,240 | £3,588 | £3,288 |
| Sales & Mktg Exp. | £86 | £71 | £68 | £70 |
| Other Operating Expenses | £0 | £0 | £0 | -£10,729 |
| Operating Expenses | £3,707 | £3,240 | £3,588 | -£7,441 |
| Operating Income | -£82,516 | £76,495 | -£36,691 | -£199,755 |
| % Margin | 106.5% | 95.2% | 97.4% | 95.3% |
| Other Income/Exp. Net | £0 | -£1,736 | -£4,551 | £7,871 |
| Pre-Tax Income | -£82,516 | £74,759 | -£41,242 | -£202,270 |
| Tax Expense | £145 | £159 | £56 | £149 |
| Net Income | -£82,661 | £74,600 | -£41,298 | -£202,419 |
| % Margin | 106.7% | 92.8% | 109.7% | 96.5% |
| EPS | -2.62 | 2.07 | -1.03 | -4.88 |
| % Growth | -226.6% | 301% | 78.9% | – |
| EPS Diluted | -2.62 | 2.07 | -1.03 | -4.88 |
| Weighted Avg Shares Out | 31,514 | 36,041 | 40,288 | 41,442 |
| Weighted Avg Shares Out Dil | 31,514 | 36,041 | 40,288 | 41,442 |
| Supplemental Information | – | – | – | – |
| Interest Income | £147 | £123 | £11 | £3 |
| Interest Expense | £1,325 | £1,115 | £792 | £175 |
| Depreciation & Amortization | £0 | £0 | £36,691 | £199,755 |
| EBITDA | -£82,516 | £0 | £0 | -£10,729 |
| % Margin | 106.5% | 0% | -0% | 5.1% |